348 related articles for article (PubMed ID: 31069878)
21. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
[TBL] [Abstract][Full Text] [Related]
22. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
[TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
[TBL] [Abstract][Full Text] [Related]
25. Macrophage migration inhibitory factor mediates skin aging via CD74: Insights from single-cell and bulk RNA sequencing data.
Wu S; Ouyang Y; Hu Y; Jiang L; Fu C; Lei L; Zhang Y; Guo H; Huang J; Chen J; Zeng Q
Clin Immunol; 2024 Jun; 263():110199. PubMed ID: 38565329
[TBL] [Abstract][Full Text] [Related]
26. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
27. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
28. Immune regulation of canine tumour and macrophage PD-L1 expression.
Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
[TBL] [Abstract][Full Text] [Related]
29. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
30. Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas.
Spurny C; Kailayangiri S; Jamitzky S; Altvater B; Wardelmann E; Dirksen U; Hardes J; Hartmann W; Rossig C
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28868758
[TBL] [Abstract][Full Text] [Related]
31. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
32. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
[TBL] [Abstract][Full Text] [Related]
33. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
34. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
35. Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma.
Han J; Xu X; Liu Z; Li Z; Wu Y; Zuo D
Int Immunopharmacol; 2020 Nov; 88():106971. PubMed ID: 33182029
[TBL] [Abstract][Full Text] [Related]
36. Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
Gowrishankar K; Gunatilake D; Gallagher SJ; Tiffen J; Rizos H; Hersey P
PLoS One; 2015; 10(4):e0123410. PubMed ID: 25844720
[TBL] [Abstract][Full Text] [Related]
37. Macrophage migration inhibitory factor regulates integrin-β1 and cyclin D1 expression via ERK pathway in podocytes.
Chen CA; Chang JM; Yang YL; Chang EE; Chen HC
Biomed Pharmacother; 2020 Apr; 124():109892. PubMed ID: 31986415
[TBL] [Abstract][Full Text] [Related]
38. BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer.
Jing X; Shao S; Zhang Y; Luo A; Zhao L; Zhang L; Gu S; Zhao X
Exp Cell Res; 2020 Jul; 392(2):112034. PubMed ID: 32339606
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
40. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
